Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.
Metman LV, Gillespie M, Farmer C, Bibbiani F, Konitsiotis S, Morris M, Shill H, Bara-Jimenez W, Mouradian MM, Chase TN. Metman LV, et al. Among authors: morris m. Clin Neuropharmacol. 2001 May-Jun;24(3):163-9. doi: 10.1097/00002826-200105000-00008. Clin Neuropharmacol. 2001. PMID: 11391128
Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.
Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN. Bara-Jimenez W, et al. Among authors: morris mj. Neurology. 2003 Aug 12;61(3):293-6. doi: 10.1212/01.wnl.0000073136.00548.d4. Neurology. 2003. PMID: 12913186 Clinical Trial.
Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.
Bara-Jimenez W, Bibbiani F, Morris MJ, Dimitrova T, Sherzai A, Mouradian MM, Chase TN. Bara-Jimenez W, et al. Among authors: morris mj. Mov Disord. 2005 Aug;20(8):932-6. doi: 10.1002/mds.20370. Mov Disord. 2005. PMID: 15791634 Clinical Trial.
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ; Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators. Rothman RL, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2439332. doi: 10.1001/jamanetworkopen.2024.39332. JAMA Netw Open. 2024. PMID: 39422912 Free PMC article. Clinical Trial.
The potential of Generative Pre-trained Transformer 4 (GPT-4) to analyse medical notes in three different languages: a retrospective model-evaluation study.
Menezes MCS, Hoffmann AF, Tan ALM, Nalbandyan M, Omenn GS, Mazzotti DR, Hernández-Arango A, Visweswaran S, Venkatesh S, Mandl KD, Bourgeois FT, Lee JWK, Makmur A, Hanauer DA, Semanik MG, Kerivan LT, Hill T, Forero J, Restrepo C, Vigna M, Ceriana P, Abu-El-Rub N, Avillach P, Bellazzi R, Callaci T, Gutiérrez-Sacristán A, Malovini A, Mathew JP, Morris M, Murthy VL, Buonocore TM, Parimbelli E, Patel LP, Sáez C, Samayamuthu MJ, Thompson JA, Tibollo V, Xia Z, Kohane IS; Consortium for Clinical Characterization of COVID-19 by Electronic Health Records. Menezes MCS, et al. Among authors: morris m. Lancet Digit Health. 2025 Jan;7(1):e35-e43. doi: 10.1016/S2589-7500(24)00246-2. Lancet Digit Health. 2025. PMID: 39722251 Free article.
Meeting report: Hidden links in autoimmunity.
Guerau-de-Arellano M, Morris MA, Sherman MA, Esch TR. Guerau-de-Arellano M, et al. Among authors: morris ma. Sci Immunol. 2024 Dec 20;9(102):eads5884. doi: 10.1126/sciimmunol.ads5884. Epub 2024 Dec 20. Sci Immunol. 2024. PMID: 39705334
5,845 results